期刊
ANNALS OF ONCOLOGY
卷 21, 期 -, 页码 199-202出版社
OXFORD UNIV PRESS
DOI: 10.1093/annonc/mdq452
关键词
adjuvant treatment; lung cancer; predictive factor; prognostic factor
类别
Adjuvant platinum-based chemotherapy represents the standard of care in fit stage II and IIIA non-small-cell lung cancer patients after surgical resection. This review discusses current knowledge on molecular prognostic and predictive tumor features for benefit from adjuvant therapies with emphasis on ongoing clinical trials that prospectively assess the biomarker utility. Until the results of these trials are available, use of these markers is not recommended in routine clinical care.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据